News
Respiratory syncytial virus is common but it can be dangerous for some infants and young kids. Here's everything parents need ...
Medical staff in Western Australia have been warned after reports of the wrong immunisations being given to patients.
An urgent warning has been issued by one Aussie health authority after medical staff reportedly gave the wrong RSV ...
The WA Department of Health has sent an urgent reminder to medical staff to make sure they’re giving patients the right RSV ...
Dr Reddy’s Laboratories prepares for US market challenges with strategic growth initiatives and strong financial performance in FY25.
A newly configured federal vaccine panel's June 25 action is expected to improve options to protect infants from potentially deadly RSV.
Gilead Sciences has blamed the low rate of respiratory syncytial virus (RSV) infections last season for ending two midstage trials of obeldesivir. | Gilead has blamed the low rate of respiratory ...
In addition to Beyfortus, the monoclonal antibody shot for babies younger than 8 months, an RSV vaccine for pregnant people became available, as did an RSV vaccine for adults ages 60 and older ...
The monoclonal antibody, given to babies under 8 months of age entering their first RSV season, is the second product of this kind to enter the market, joining Sanofi and AstraZeneca’s Beyfortus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results